Evidence map›Paper›PMID 31358980›Full record

ArticleNature microbiology2019

The impact of antimicrobials on gonococcal evolution.

Leonor Sánchez-Busó, Daniel Golparian, Jukka Corander, Yonatan H Grad, Makoto Ohnishi, Rebecca Flemming, Julian Parkhill, Stephen D Bentley, Magnus Unemo, Simon R Harris

Abstract read
In one paragraph

Article in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 2 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. The frequency of mutations in theFrontiers in microbiology · 2024
    Pooled it
  2. Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021
    Guideline
  3. Trial
  4. Rapid detection of ceftriaxone-resistantMicrobiology spectrum · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  10. Gene exchange betweenMicrobial genomics · 2026
    Article
  11. eLife · 2025
    Article
  12. Article
  13. Genome analysis ofMicrobial genomics · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Complete reference genomes of two ceftriaxone-resistantMicrobiology resource announcements · 2024
    Article
  20. Emergence and evolution of mosaicFrontiers in microbiology · 2024
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 6 countries.

Leonor Sánchez-BusóPathogen Genomics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-4162-0228
Daniel GolparianWHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Jukka CoranderPathogen Genomics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Yonatan H GradDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5646-1314
Makoto OhnishiDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Rebecca FlemmingFaculty of Classics, University of Cambridge, Cambridge, UK.
Julian ParkhillPathogen Genomics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-7069-5958
Stephen D BentleyPathogen Genomics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Magnus UnemoWHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Simon R HarrisPathogen Genomics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. sh16@sanger.ac.uk.ORCID http://orcid.org/0000-0003-1512-6194
Wellcome Sanger Institute · GBÖrebro University · SEBrigham and Women's Hospital · USNational Institute of Infectious Diseases · JPUniversity of Cambridge · GBUniversity of Helsinki · FI

Funding

Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeaeR01AI132606 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Yonatan H Grad · 2017 to 2026
$3.8M
NIAID NIH HHS R01 AI132606Wellcome Trust 098051
6 · The paper itself

Abstract

The sexually transmitted pathogen Neisseria gonorrhoeae is regarded as being on the way to becoming an untreatable superbug. Despite its clinical importance, little is known about its emergence and evolution, and how this corresponds with the introduction of antimicrobials. We present a genome-based phylogeographical analysis of 419 gonococcal isolates from across the globe. Results indicate that modern gonococci originated in Europe or Africa, possibly as late as the sixteenth century and subsequently disseminated globally. We provide evidence that the modern gonococcal population has been shaped by antimicrobial treatment of sexually transmitted infections as well as other infections, leading to the emergence of two major lineages with different evolutionary strategies. The well-described multidrug-resistant lineage is associated with high rates of homologous recombination and infection in high-risk sexual networks. A second, multisusceptible lineage is more associated with heterosexual networks, with potential implications for infection control.

Indexed as

Drug Resistance, Multiple, BacterialAfricaAnti-Bacterial AgentsDNA, BacterialEuropeEvolution, MolecularGonorrheaHomologous RecombinationHumansNeisseria gonorrhoeaePhylogenyPhylogeographySequence Analysis, DNAAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID31358980
PMCPMC6817357
OpenAlexW2966082154

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.